<DOC>
	<DOCNO>NCT00247026</DOCNO>
	<brief_summary>To determine clinical effect coenzyme Q10 Curcumin improve cytopenias patient myelodysplastic syndrome . propose explore efficacy natural compound curcumin CoQ10 MDS two agent possess many effect desirable MDS .</brief_summary>
	<brief_title>The Efficacy Coenzyme Q10 And Curcumin Patients With Myelodysplastic Syndromes</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Curcumin</mesh_term>
	<mesh_term>Coenzyme Q10</mesh_term>
	<mesh_term>Ubiquinone</mesh_term>
	<criteria>MDS patient RA , RARS RAEB eligible treatment CoQ10 long IPSS score â‰¤ 1.5 . Pregnant woman nurse woman exclude . History clinically significant liver kidney disease . ECOG &gt; 2 IPSS score &gt; 1.5 Poorly control diabetes mellitus , hypertension , serious medical psychiatric illness could potentially interfere completion treatment accord protocol .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2007</verification_date>
	<keyword>myelodysplasia</keyword>
	<keyword>curcumin</keyword>
	<keyword>coenzyme Q10</keyword>
	<keyword>cytopenia</keyword>
</DOC>